Skip to main content
Premium Trial:

Request an Annual Quote

Invitae Extends Loan Agreement for $20M

NEW YORK (GenomeWeb) – Invitae has reached an agreement with Oxford Finance to extend its existing loan and security agreement by $20 million.

The first tranche of the credit facility with Oxford Finance closed a year ago and provided Invitae with $40 million in gross proceeds. With half those proceeds still available to use at its discretion, the new amendment to the agreement raises the total capital available to Invitae to $40 million more.

The additional $20 million can be funded at Invitae's option during the second quarter of 2018, and will provide the firm with "additional flexibility" throughout the year as it grows its genome network.

The loan matures in March 2022 and is subject to quarterly covenants, including achieving certain volume and revenue levels.

The Scan

And a Fourth?

A fourth dose of the Pfizer-BioNTech SARS-CoV-2 vaccine in an Israeli study increased antibody levels but did not prevent Omicron variant infections, according to the Financial Times.

For Better Science Software

A virtual institute funded by former Google CEO Eric Schmidt's philanthropy aims to lure software engineers to academia, Science reports.

Recommendation Explanations

The New York Times writes that the US Centers for Disease Control and Prevention is straining to both make and explain decisions based on limited information.

Genome Research Papers on De Novo Mutation Rates, Polyploid Genotyping, Oncogene Epigenomic Translocation

In Genome Research this week: de novo mutations rates in hemoglobin subunits, analysis of variant calling methods for polyploid plants, and more.